- Hopewell Junction, New York-based eMagin Corp EMAN reported fourth-quarter FY22 revenue growth of 17% year-on-year to $8.39 million.
- Bookings for the fourth quarter were strong, including a $1.7 million order for the F-35 Helmet Mounted Display System and more than $2 million in medical applications.
- The backlog of open orders as of Dec. 31, 2022, shippable within 12 months, was $14.8 million.
- Segments: Product revenue rose 10.5% Y/Y to $7.75 million, primarily due to increased military market revenues.
- Due to higher product revenues, the gross margin expanded by 1,700 bps to 41%.
- The operating loss improved to $(0.1) million versus $(1.8) million a year ago.
- EPS was $0.01.
- eMagin held $4.3 million in cash and equivalents.
- Price Action: EMAN shares closed higher by 2.83% at $1.09 on Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in